Skip to main content
Top
Published in: Respiratory Research 1/2022

Open Access 01-12-2022 | Expectoration | Research

Black carbon content in airway macrophages is associated with increased severe exacerbations and worse COPD morbidity in SPIROMICS

Authors: Vickram Tejwani, Han Woo, Chen Liu, Anna K. Tillery, Amanda J. Gassett, Richard E. Kanner, Eric A. Hoffman, Fernando J. Martinez, Prescott G. Woodruff, R. Graham Barr, Ashraf Fawzy, Kirsten Koehler, Jeffrey L. Curtis, Christine M. Freeman, Christopher B. Cooper, Alejandro P. Comellas, Cheryl Pirozzi, Robert Paine, Donald Tashkin, Jerry A. Krishnan, Coralynn Sack, Nirupama Putcha, Laura M. Paulin, Marina Zusman, Joel D. Kaufman, Neil E. Alexis, Nadia N. Hansel

Published in: Respiratory Research | Issue 1/2022

Login to get access

Abstract

Background

Airway macrophages (AM), crucial for the immune response in chronic obstructive pulmonary disease (COPD), are exposed to environmental particulate matter (PM), which they retain in their cytoplasm as black carbon (BC). However, whether AM BC accurately reflects environmental PM2.5 exposure, and can serve as a biomarker of COPD outcomes, is unknown.

Methods

We analyzed induced sputum from participants at 7 of 12 sites SPIROMICS sites for AM BC content, which we related to exposures and to lung function and respiratory outcomes. Models were adjusted for batch (first vs. second), age, race (white vs. non-white), income (<$35,000, $35,000~$74,999, ≥$75,000, decline to answer), BMI, and use of long-acting beta-agonist/long-acting muscarinic antagonists, with sensitivity analysis performed with inclusion of urinary cotinine and lung function as covariates.

Results

Of 324 participants, 143 were current smokers and 201 had spirometric-confirmed COPD. Modeled indoor fine (< 2.5 μm in aerodynamic diameter) particulate matter (PM2.5) and urinary cotinine were associated with higher AM BC. Other assessed indoor and ambient pollutant exposures were not associated with higher AM BC. Higher AM BC was associated with worse lung function and odds of severe exacerbation, as well as worse functional status, respiratory symptoms and quality of life.

Conclusion

Indoor PM2.5 and cigarette smoke exposure may lead to increased AM BC deposition. Black carbon content in AMs is associated with worse COPD morbidity in current and former smokers, which remained after sensitivity analysis adjusting for cigarette smoke burden. Airway macrophage BC, which may alter macrophage function, could serve as a predictor of experiencing worse respiratory symptoms and impaired lung function.
Appendix
Available only for authorised users
Literature
1.
go back to reference Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, 2021. [Internet]. 2021 [cited 2021 Oct 8]. Available from: https://goldcopd.org/. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, 2021. [Internet]. 2021 [cited 2021 Oct 8]. Available from: https://​goldcopd.​org/​.
2.
go back to reference Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–128.CrossRefPubMed Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–128.CrossRefPubMed
4.
go back to reference Atkinson RW, Kang S, Anderson HR, Mills IC, Walton HA. Epidemiological time series studies of PM2.5 and daily mortality and hospital admissions: A systematic review and meta-analysis. Thorax. 2014. Atkinson RW, Kang S, Anderson HR, Mills IC, Walton HA. Epidemiological time series studies of PM2.5 and daily mortality and hospital admissions: A systematic review and meta-analysis. Thorax. 2014.
5.
go back to reference Dominici F, Peng RD, Bell ML, Pham L, McDermott A, Zeger SL, et al. Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. J Am Med Assoc. 2006. Dominici F, Peng RD, Bell ML, Pham L, McDermott A, Zeger SL, et al. Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. J Am Med Assoc. 2006.
6.
go back to reference Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature. 2013. Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature. 2013.
7.
go back to reference Vlahos R, Bozinovski S. Role of alveolar macrophages in chronic obstructive pulmonary disease. Frontiers in Immunology. 2014. Vlahos R, Bozinovski S. Role of alveolar macrophages in chronic obstructive pulmonary disease. Frontiers in Immunology. 2014.
8.
go back to reference Yamasaki K, Van Eeden SF. Lung macrophage phenotypes and functional responses: Role in the pathogenesis of COPD. International Journal of Molecular Sciences. 2018. Yamasaki K, Van Eeden SF. Lung macrophage phenotypes and functional responses: Role in the pathogenesis of COPD. International Journal of Molecular Sciences. 2018.
10.
go back to reference Bai Y, Brugha RE, Jacobs L, Grigg J, Nawrot TS, Nemery B. Carbon loading in airway macrophages as a biomarker for individual exposure to particulate matter air pollution - A critical review. Environment International. 2015. Bai Y, Brugha RE, Jacobs L, Grigg J, Nawrot TS, Nemery B. Carbon loading in airway macrophages as a biomarker for individual exposure to particulate matter air pollution - A critical review. Environment International. 2015.
11.
go back to reference Nwokoro C, Ewin C, Harrison C, Ibrahim M, Dundas I, Dickson I, et al. Cycling to work in London and inhaled dose of black carbon. Eur Respir J. 2012. Nwokoro C, Ewin C, Harrison C, Ibrahim M, Dundas I, Dickson I, et al. Cycling to work in London and inhaled dose of black carbon. Eur Respir J. 2012.
12.
go back to reference Brugha RE, Mushtaq N, Round T, Gadhvi DH, Dundas I, Gaillard E, et al. Carbon in airway macrophages from children with asthma. Thorax. 2014. Brugha RE, Mushtaq N, Round T, Gadhvi DH, Dundas I, Gaillard E, et al. Carbon in airway macrophages from children with asthma. Thorax. 2014.
13.
go back to reference Fullerton DG, Jere K, Jambo K, Kulkarni NS, Zijlstra EE, Grigg J, et al. Domestic smoke exposure is associated with alveolar macrophage particulate load. Trop Med Int Heal. 2009. Fullerton DG, Jere K, Jambo K, Kulkarni NS, Zijlstra EE, Grigg J, et al. Domestic smoke exposure is associated with alveolar macrophage particulate load. Trop Med Int Heal. 2009.
14.
go back to reference Belli AJ, Bose S, Aggarwal N, DaSilva C, Thapa S, Grammer L, et al. Indoor particulate matter exposure is associated with increased black carbon content in airway macrophages of former smokers with COPD. Environ Res. 2016. Belli AJ, Bose S, Aggarwal N, DaSilva C, Thapa S, Grammer L, et al. Indoor particulate matter exposure is associated with increased black carbon content in airway macrophages of former smokers with COPD. Environ Res. 2016.
15.
go back to reference Tejwani V, Moughames E, Suresh K, Tang S-E, Mair LG, Romero K, et al. Black Carbon Content in Airway Macrophages is Associated with Reduced CD80 Expression and Increased Exacerbations in Former Smokers With COPD. Chronic Obstr Pulm Dis (Miami, Fla) [Internet]. 2020 Nov 6; Available from: http://www.ncbi.nlm.nih.gov/pubmed/33156984. Tejwani V, Moughames E, Suresh K, Tang S-E, Mair LG, Romero K, et al. Black Carbon Content in Airway Macrophages is Associated with Reduced CD80 Expression and Increased Exacerbations in Former Smokers With COPD. Chronic Obstr Pulm Dis (Miami, Fla) [Internet]. 2020 Nov 6; Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​33156984.
16.
go back to reference Dewhurst JA, Lea S, Hardaker E, Dungwa JV, Ravi AK, Singh D. Characterisation of lung macrophage subpopulations in COPD patients and controls. Sci Rep. 2017. Dewhurst JA, Lea S, Hardaker E, Dungwa JV, Ravi AK, Singh D. Characterisation of lung macrophage subpopulations in COPD patients and controls. Sci Rep. 2017.
17.
go back to reference Lea S, Dungwa J, Ravi A, Singh D. Alveolar macrophage size is increased in COPD patients compared to controls. In 2017. Lea S, Dungwa J, Ravi A, Singh D. Alveolar macrophage size is increased in COPD patients compared to controls. In 2017.
18.
go back to reference Hansel NN, Paulin LM, Gassett AJ, Peng RD, Alexis N, Fan VS, et al. Design of the subpopulations and intermediate outcome measures in COPD (SPIROMICS) AIR study. BMJ Open Respir Res. 2017. Hansel NN, Paulin LM, Gassett AJ, Peng RD, Alexis N, Fan VS, et al. Design of the subpopulations and intermediate outcome measures in COPD (SPIROMICS) AIR study. BMJ Open Respir Res. 2017.
19.
go back to reference Alexis N, Soukup J, Ghio A, Becker S. Sputum phagocytes from healthy individuals are functional and activated: A flow cytometric comparison with cells in bronchoalveolar lavage and peripheral blood. Clin Immunol. 2000. Alexis N, Soukup J, Ghio A, Becker S. Sputum phagocytes from healthy individuals are functional and activated: A flow cytometric comparison with cells in bronchoalveolar lavage and peripheral blood. Clin Immunol. 2000.
20.
go back to reference Kulkarni NS, Prudon B, Panditi SL, Abebe Y, Grigg J. Carbon loading of alveolar macrophages in adults and children exposed to biomass smoke particles. Sci Total Environ. 2005. Kulkarni NS, Prudon B, Panditi SL, Abebe Y, Grigg J. Carbon loading of alveolar macrophages in adults and children exposed to biomass smoke particles. Sci Total Environ. 2005.
21.
go back to reference Sampson PD, Szpiro AA, Sheppard L, Lindström J, Kaufman JD. Pragmatic estimation of a spatio-temporal air quality model with irregular monitoring data. Atmos Environ. 2011. Sampson PD, Szpiro AA, Sheppard L, Lindström J, Kaufman JD. Pragmatic estimation of a spatio-temporal air quality model with irregular monitoring data. Atmos Environ. 2011.
22.
go back to reference Szpiro AA, Sampson PD, Sheppard L, Lumley T, Adar SD, Kaufman JD. Predicting intra-urban variation in air pollution concentrations with complex spatio-temporal dependencies. Environmetrics. 2010. Szpiro AA, Sampson PD, Sheppard L, Lumley T, Adar SD, Kaufman JD. Predicting intra-urban variation in air pollution concentrations with complex spatio-temporal dependencies. Environmetrics. 2010.
23.
go back to reference Zusman M, Gassett AJ, Kirwa K, Barr RG, Cooper CB, Han MK, et al. “Modeling Residential Indoor Concentrations of PM 2.5, NO 2, NO x, and secondhand smoke in the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) Air Study”. Indoor Air. 2020. Zusman M, Gassett AJ, Kirwa K, Barr RG, Cooper CB, Han MK, et al. “Modeling Residential Indoor Concentrations of PM 2.5, NO 2, NO x, and secondhand smoke in the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) Air Study”. Indoor Air. 2020.
24.
go back to reference Goniewicz ML, Eisner MD, Lazcano-ponce E, Zielinska-danch W, Koszowski B, Sobczak A, et al. Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smoking. Nicotine Tob Res. 2011. Goniewicz ML, Eisner MD, Lazcano-ponce E, Zielinska-danch W, Koszowski B, Sobczak A, et al. Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smoking. Nicotine Tob Res. 2011.
25.
go back to reference Standardization of Spirometry. 1994 Update. American Thoracic Society. Am J Respir Crit Care Med. 1995. Standardization of Spirometry. 1994 Update. American Thoracic Society. Am J Respir Crit Care Med. 1995.
26.
go back to reference Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George’s Respiratory Questionnaire. Am Rev Respir Dis. 1992. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George’s Respiratory Questionnaire. Am Rev Respir Dis. 1992.
27.
go back to reference Jones PW, Harding G, Berry P, Wiklund I, Chen WH. Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009. Jones PW, Harding G, Berry P, Wiklund I, Chen WH. Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009.
28.
go back to reference Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988.
29.
go back to reference Rubin BK, Ramirez O, Ohar JA. Iodinated glycerol has no effect on pulmonary function, symptom score, or sputum properties in patients with stable chronic bronchitis. Chest. 1996. Rubin BK, Ramirez O, Ohar JA. Iodinated glycerol has no effect on pulmonary function, symptom score, or sputum properties in patients with stable chronic bronchitis. Chest. 1996.
30.
go back to reference Kim V, Zhao H, Regan E, Han MLK, Make BJ, Crapo JD, et al. The St. George’s Respiratory Questionnaire Definition of Chronic Bronchitis May Be a Better Predictor of COPD Exacerbations Compared With the Classic Definition. Chest. 2019. Kim V, Zhao H, Regan E, Han MLK, Make BJ, Crapo JD, et al. The St. George’s Respiratory Questionnaire Definition of Chronic Bronchitis May Be a Better Predictor of COPD Exacerbations Compared With the Classic Definition. Chest. 2019.
31.
go back to reference American Thoracic Society. Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002. American Thoracic Society. Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002.
32.
go back to reference Kulkarni N, Pierse N, Rushton L, Grigg J. Carbon in airway macrophages and lung function in children. N Engl J Med. 2006. Kulkarni N, Pierse N, Rushton L, Grigg J. Carbon in airway macrophages and lung function in children. N Engl J Med. 2006.
33.
go back to reference Klepeis NE, Nelson WC, Ott WR, Robinson JP, Tsang AM, Switzer P, et al. The National Human Activity Pattern Survey (NHAPS): A resource for assessing exposure to environmental pollutants. J Expo Anal Environ Epidemiol. 2001. Klepeis NE, Nelson WC, Ott WR, Robinson JP, Tsang AM, Switzer P, et al. The National Human Activity Pattern Survey (NHAPS): A resource for assessing exposure to environmental pollutants. J Expo Anal Environ Epidemiol. 2001.
34.
go back to reference Beals T, Fligiel S, Stuth S, Gong H, Tashkin D. Morphometry of alveolar macrophages from smokers of marijuana, tobacco, and cocaine. In: 77th Annual Meeting of the United States and Canadian Academy of Pathology. 1988. Beals T, Fligiel S, Stuth S, Gong H, Tashkin D. Morphometry of alveolar macrophages from smokers of marijuana, tobacco, and cocaine. In: 77th Annual Meeting of the United States and Canadian Academy of Pathology. 1988.
35.
go back to reference Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ, et al. Outcomes for COPD pharmacological trials: From lung function to biomarkers. Eur Respir J. 2008;Vol. 31:416–68.CrossRefPubMed Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ, et al. Outcomes for COPD pharmacological trials: From lung function to biomarkers. Eur Respir J. 2008;Vol. 31:416–68.CrossRefPubMed
36.
37.
go back to reference Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med [Internet]. 1996 Feb;153(2):530–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8564092. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med [Internet]. 1996 Feb;153(2):530–4. Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​8564092.
38.
go back to reference Yin G, Wu X, Wu Y, Li H, Gao L, Zhu X, et al. Evaluating carbon content in airway macrophages as a biomarker of personal exposure to fine particulate matter and its acute respiratory effects. Chemosphere [Internet]. 2021 Jun 14;283:131179. Available from: http://www.ncbi.nlm.nih.gov/pubmed/34146873. Yin G, Wu X, Wu Y, Li H, Gao L, Zhu X, et al. Evaluating carbon content in airway macrophages as a biomarker of personal exposure to fine particulate matter and its acute respiratory effects. Chemosphere [Internet]. 2021 Jun 14;283:131179. Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​34146873.
39.
go back to reference Jacobs L, Emmerechts J, Mathieu C, Hoylaerts MF, Fierens F, Hoet PH, et al. Air pollution-related prothrombotic changes in persons with diabetes. Environ Health Perspect. 2010. Jacobs L, Emmerechts J, Mathieu C, Hoylaerts MF, Fierens F, Hoet PH, et al. Air pollution-related prothrombotic changes in persons with diabetes. Environ Health Perspect. 2010.
40.
go back to reference Thomas ED, Ramberg RE, Sale GE, Sparkes RS, Golde DW. Direct evidence for a bone marrow origin of the alveolar macrophage in man. Science (80-). 1976. Thomas ED, Ramberg RE, Sale GE, Sparkes RS, Golde DW. Direct evidence for a bone marrow origin of the alveolar macrophage in man. Science (80-). 1976.
Metadata
Title
Black carbon content in airway macrophages is associated with increased severe exacerbations and worse COPD morbidity in SPIROMICS
Authors
Vickram Tejwani
Han Woo
Chen Liu
Anna K. Tillery
Amanda J. Gassett
Richard E. Kanner
Eric A. Hoffman
Fernando J. Martinez
Prescott G. Woodruff
R. Graham Barr
Ashraf Fawzy
Kirsten Koehler
Jeffrey L. Curtis
Christine M. Freeman
Christopher B. Cooper
Alejandro P. Comellas
Cheryl Pirozzi
Robert Paine
Donald Tashkin
Jerry A. Krishnan
Coralynn Sack
Nirupama Putcha
Laura M. Paulin
Marina Zusman
Joel D. Kaufman
Neil E. Alexis
Nadia N. Hansel
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2022
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-022-02225-0

Other articles of this Issue 1/2022

Respiratory Research 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine